Main Article Content
New Trends in Neuro-protection in Glaucoma
Abstract
Recent advancements in neuroprotection for glaucoma have seen a shift towards multifaceted approaches targeting various aspects of the disease's pathophysiology. Traditional strategies were primarily focused on lowering intraocular pressure (IOP) but emerging trends highlight the importance of preserving retinal ganglion cells (RGCs) and their axons. Novel therapeutics aim to enhance neurotrophic support, reduce excitotoxicity, and mitigate oxidative stress, complementing IOP-lowering therapies for comprehensive management. Stem cell therapies, neurotrophic factors, and gene therapies show promise in promoting RGC survival and axonal regeneration. Additionally, the repurposing of existing drugs, such as calcium channel blockers and anti-inflammatory agents, for neuro-protection in glaucoma underscores the importance of exploring diverse mechanisms. These innovative approaches represent a paradigm shift in glaucoma management, emphasizing the need for a holistic approach targeting both IOP and neuroprotection to preserve vision effectively.